Clinical Trial Update: Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, and efficacy of YHD001 in patients with acute and chronic bronchitis. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• YHD001

Snippet

Sponsor: Yuhan Corporation | Conditions: Acute Bronchitis, Chronic Bronchitis | Phase 2 | Status: COMPLETED